“Artificial intelligence” … the term is everywhere these days, but what exactly does it mean? As of this writing, the Wikipedia page for AI cites almost 300 references discussing and defining the topic. So much is being written about it every day … how do you even process a fraction of it? How do pharma marketers begin to understand what it is and how it can help their brands? We’ve created a glossary to help you understand the most commonly used terms.
Why AI Equity Is the Next Step for Transformational Pharma
Artificial intelligence is here to stay, and it has the potential to improve health outcomes when done right. But is the data informing your AI biased? How can you know, and what can you do about it? Intouch’s VP of innovation, Abid Rahman, shares insights and advice.
Intouch & Athenex Oncology Talk AI at Frontiers Health Global Hybrid Conference
What’s the best approach for investments in AI-based implementations? At this year’s Frontiers Health conference, Intouch experts will discuss the ‘what’ and ‘how’; we’ll also hear a case study on creating an augmented-reality tool to help oncology HCPs empathize with patients undergoing chemotherapy, developed together with Athenex Oncology.